<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Pharmaceutical and Biomedical Research</title>
<title_fa></title_fa>
<short_title>Pharm Biomed Res</short_title>
<subject>Medical Sciences</subject>
<web_url>http://pbr.mazums.ac.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2423-4486</journal_id_issn>
<journal_id_issn_online>2423-4494</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.29252/pbr</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai>8888</journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1404</year>
	<month>12</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2026</year>
	<month>3</month>
	<day>1</day>
</pubdate>
<volume>12</volume>
<number>2</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Anticancer 1,3-thiazole Derivatives: In Vitro Evaluation and in Silico Tubulin/Lipoxygenase Inhibition</title>
	<subject_fa>بیولوژی سلولی- مولکولی</subject_fa>
	<subject>Cellular and Molecular Biology</subject>
	<content_type_fa>پژوهشي</content_type_fa>
	<content_type>Original Research</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;div style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Background&lt;/strong&gt;: Addressing cancer treatment and drug resistance is critical because cancer remains a leading cause of death worldwide. Targeting key enzymes, such as tubulin and lipoxygenase, may yield new strategies to impede tumor growth and enhance treatment efficacy.&lt;br&gt;
&lt;strong&gt;Objectives&lt;/strong&gt;: This study aimed to evaluate the anticancer effects of 1,3-thiazole derivatives on A549 and HT-29 cancer cell lines and investigate their ability to inhibit tubulin and lipoxygenase enzymes.&lt;br&gt;
&lt;strong&gt;Methods&lt;/strong&gt;: Ethyl and methyl derivatives with a central 1,3-thiazole core were synthesized in one step. A549 and HT-29 cells were cultured in RPMI 1640 medium. The cytotoxic effects of the derivatives were assessed by treating the cells with varying concentrations for 24, 48, and 72 hours, followed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays. Molecular docking using AutoDock Vina software, version 1.1.2 was performed to evaluate the derivatives&amp;rsquo; inhibitory effects on tubulin and lipoxygenase.&lt;br&gt;
&lt;strong&gt;Results&lt;/strong&gt;: Compound A demonstrated significant anticancer activity against A549 cells at 500 &amp;micro;g/mL. Compound B also inhibited 50% of cancer cells at 1000 &amp;micro;g/mL. In the HT-29 cell line, compound A reduced cell viability by 50% at 500 &amp;micro;g/mL, while compound B showed stronger effects at the same concentration. Ligand A exhibited notable inhibitory potential against tubulin, whereas ligand B had significant inhibitory effects against tubulin and lipoxygenase.&lt;br&gt;
&lt;strong&gt;Conclusion&lt;/strong&gt;: The ethyl substituent of the 1,3-thiazole core shows promise as an anticancer agent against A549, while the methyl substituent is effective against HT-29. Both derivatives can inhibit tubulin function.&lt;/div&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Thiazoles, A549 cells, HT-29 cells, Tubulin, Lipoxygenase, Molecular docking</keyword>
	<start_page>87</start_page>
	<end_page>98</end_page>
	<web_url>http://pbr.mazums.ac.ir/browse.php?a_code=A-10-1379-1&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Yasin</first_name>
	<middle_name></middle_name>
	<last_name>SarveAhrabi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>yasin.ahrabi2016@gmail.com</email>
	<code>100319475328460012148</code>
	<orcid>100319475328460012148</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Biology, CT.C., Islamic Azad University, Tehran, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Saina</first_name>
	<middle_name></middle_name>
	<last_name>Aqa Abedi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>abedisaina13@gmail.com</email>
	<code>100319475328460012149</code>
	<orcid>0009-0000-1531-2857</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Biology, CT.C., Islamic Azad University, Tehran, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Mastaneh</first_name>
	<middle_name></middle_name>
	<last_name>Ahmadirad</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>mastaneh.ah@gmail.com</email>
	<code>100319475328460012150</code>
	<orcid>100319475328460012150</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Biology, CT.C., Islamic Azad University, Tehran, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Nakisa</first_name>
	<middle_name></middle_name>
	<last_name>Zarrabi Ahrabi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>na.zarrabi@iauctb.ac.ir</email>
	<code>100319475328460012151</code>
	<orcid>100319475328460012151</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Department of Biology, CT.C., Islamic Azad University, Tehran, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
